reduc estimate reflect
reiter outperform
chang model made chang model reflect analysi
framework assess potenti impact coronaviru zbh major
busi reduc ep estim
respect also reduc sale estim
respect reflect organ growth
respect previou estim despit rapidli
evolv natur outbreak uncertainti regard scope
durat effect view analysi framework reason guid
potenti rang effect comfort point base case
scenario reflect new estim middl rang lower
target price reiter under-perform rate
new estim reflect base case assumpt across rang risk
factor analysi contempl potenti impact defer procedur
procedur less deferr capit equip flu care diagnost
busi line also take account geograph exposur zbh major
busi china apac ex-china ou ex-apac us final consid
potenti rang durat may see pressur slowdown variou
busi base case assumpt durat impact last
recaptur percentag lost defer
procedur period end market stabil addit detail
analysi behind estim chang pleas see correspond sector updat
estim cut reduc estim includ
addit background
valuat price target previous base ev/ebitda
multipl previous ebitda bil bil risk re-
acceler us knee implant sale faster uptak rosa knee
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
inc global manufactur provid
medic devic equip treatment musculoskelet
spinal disord trauma dental implant
one-year valuat scenario base
ev/ebitda ebitda
one-year valuat grey scenario base
ev/ebitda grey ebitda
 close
chang model
figur chang model
compani mention price
matt miksic certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
